ClinicalTrialsFinder

Sjogren Disease Clinical Trials in Orlando, Florida

1 recruitingOrlando, Florida

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Sjogren's SyndromeSjogren DiseaseSjögren
Cullinan Therapeutics Inc.36 enrolled11 locationsNCT07041099